Lorcaserin (Epygenix Therapeutics/University of California at San Fransisco) | Interleukin Related interleukin-related.com

Product Name :
Lorcaserin (Epygenix Therapeutics/University of California at San Fransisco)

Search keywords :
EPX

drugId :
null

Target Vo:
Serotonin 2c (5-HT2c) receptor

Target Vo Short Name :
5-HT2C

Moa_Name:
Serotonin 2c (5-HT2c) receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of California San Diego

Active Company_Name :
Epygenix Therapeutics Inc

Active Indication_Name:
Brain Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bedinvetmab Protein Tyrosine Kinase/RTK
SOX10 Rabbit mAb Technical Information
FOXO1A Antibody: FOXO1A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to FOXO1A. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts